Howard G. Welgus is Director at Arcutis Biotherapeutics, Inc. (ARQT). They have made 24 open-market trades across 1 company since 2020, most recently 2026-09-15.
CIK 0001801050
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 24 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ARQT | 35,841 | $1.0M |
Shares reported on the most recent Form 4, priced at the 2026-09-17 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARQT | SELL · 10b5-1 | 2026-09-15 | 2026-09-17 | $24.18 | $114K | +1.1% | — | — |
| ARQT | SELL · 10b5-1 | 2026-08-17 | 2026-08-19 | $26.18 | $124K | -8.7% | -3.3% | — |
| ARQT | SELL · 10b5-1 | 2026-07-15 | 2026-07-17 | $26.91 | $127K | -3.4% | -11.3% | +0.8% |
| ARQT | SELL · 10b5-1 | 2026-06-15 | 2026-06-17 | $24.58 | $116K | -1.4% | +6.9% | -11.6% |
| ARQT | SELL · 10b5-1 | 2026-05-01 | 2026-05-05 | $22.99 | $164K | -10.2% | -7.6% | +9.3% |
| ARQT | SELL · 10b5-1 | 2026-04-01 | 2026-04-03 | $23.88 | $239K | +3.8% | -0.7% | +9.0% |
| ARQT | SELL · 10b5-1 | 2026-03-02 | 2026-03-04 | $25.65 | $257K | -4.0% | -0.2% | -12.3% |
| ARQT | SELL | 2026-02-02 | 2026-02-04 | $25.05 | $250K | +1.6% | -8.3% | -10.5% |
| ARQT | SELL | 2026-01-02 | 2026-01-06 | $28.96 | $290K | -12.0% | -11.2% | -19.5% |
| ARQT | SELL · 10b5-1 | 2025-12-01 | 2025-12-03 | $30.21 | $302K | -1.4% | -1.3% | -19.7% |
| ARQT | SELL · 10b5-1 | 2025-11-03 | 2025-11-05 | $25.27 | $253K | +9.4% | +30.4% | +9.4% |
| ARQT | SELL · 10b5-1 | 2025-10-01 | 2025-10-03 | $18.92 | $370K | +8.7% | +24.5% | +45.8% |
| ARQT | SELL · 10b5-1 | 2025-09-02 | 2025-09-04 | $15.64 | $156K | +4.5% | +21.7% | +84.5% |
| ARQT | SELL · 10b5-1 | 2025-08-01 | 2025-08-05 | $14.30 | $143K | +12.2% | +7.7% | +64.5% |
| ARQT | SELL · 10b5-1 | 2025-07-01 | 2025-07-02 | $13.84 | $255K | +11.8% | +3.7% | +36.8% |
| ARQT | SELL · 10b5-1 | 2025-06-18 | 2025-06-20 | $13.37 | $271K | +0.6% | +4.8% | +29.5% |
| ARQT | SELL · 10b5-1 | 2025-05-01 | 2025-05-05 | $14.64 | $146K | -9.0% | -11.4% | -3.0% |
| ARQT | SELL · 10b5-1 | 2025-04-01 | 2025-04-03 | $15.12 | $151K | -15.4% | -1.2% | -11.8% |
| ARQT | SELL · 10b5-1 | 2025-03-03 | 2025-03-04 | $13.00 | $130K | +9.5% | +21.0% | +1.0% |
| ARQT | SELL · 10b5-1 | 2025-02-03 | 2025-02-04 | $12.71 | $254K | -2.7% | +10.4% | +17.4% |
| ARQT | SELL · 10b5-1 | 2025-01-02 | 2025-01-06 | $14.67 | $147K | -16.2% | -12.9% | -5.5% |
| ARQT | SELL · 10b5-1 | 2024-12-02 | 2024-12-03 | $12.51 | $125K | +1.6% | +16.6% | +2.7% |
| ARQT | SELL · 10b5-1 | 2024-11-01 | 2024-11-05 | $8.65 | $87K | -1.2% | +31.4% | +35.4% |
| ARQT | SELL · 10b5-1 | 2024-10-01 | 2024-10-03 | $9.26 | $93K | -8.3% | -14.5% | +42.7% |
| ARQT | SELL · 10b5-1 | 2024-09-03 | 2024-09-05 | $10.77 | $108K | -4.2% | -9.5% | +16.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.